Application of Guideline-Based Echocardiographic Assessment of Left Atrial Pressure to Heart Failure with Preserved Ejection Fraction.

Application of Guideline-Based Echocardiographic Assessment of Left Atrial Pressure to Heart Failure with Preserved Ejection Fraction.
复制标题

DOI:
10.1016/j.echo.2020.12.008
复制
发表时间:
2021-05
期刊:
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
影响因子:
--
通讯作者:
Patel RB
Patel RB
中科院分区:
其他
文献类型:
--
作者:
Rethy L;Borlaug BA;Redfield MM;Oh JK;Shah SJ;Patel RB

文献摘要

参考文献

被引文献

相似文献

早期、无创地识别射血分数保留的心力衰竭(HFpEF)合并淤血的患者,可能有助于及时调整去淤血治疗。2016年美国超声心动图学会/欧洲心血管影像协会指南提供了一种评估左心房压力(LAP)升高的算法;超声心动图LAP(echo - LAP)与HFpEF的临床状态和疾病进展的关联尚不清楚。 我们将磷酸二酯酶 - 5抑制剂改善射血分数保留的心力衰竭患者临床状态和运动能力(RELAX)试验的参与者按照预先指定的基于指南的echo - LAP类别分为4类中的1类:1)正常,2)升高,3)超声心动图检查时存在心房颤动(AF),或4)不确定。我们评估了echo - LAP类别与基线运动能力、运动能力变化以及24周内N末端B型利钠肽原(NT - proBNP)变化的关联。 在216名参与者中,199人进行了二尖瓣流入道多普勒超声心动图检查以进行LAP分类。echo - LAP升高(n = 81)或存在AF(n = 57)的参与者年龄较大,肾功能障碍患病率较高。与正常echo - LAP组(n = 28)相比,在调整基线值和临床协变量后,echo - LAP升高和AF各自独立地与24周内峰值耗氧量的更大幅度降低相关(echo - LAP升高的β系数:−1.55[95%置信区间:−2.59,−0.51],p = 0.004;AF的β系数:−1.33[95%置信区间:−2.49,−0.17],p = 0.03)。与正常echo - LAP相比,不确定的echo - LAP(n = 33)也独立地与24周时运动能力降低相关(β系数:−1.35[95%置信区间:−2.51,−0.19],p = 0.02)。最后,与正常echo - LAP相比,echo - LAP升高和AF与24周内NT - proBNP升高显著相关。 在慢性HFpEF中,按照当代指南定义的echo - LAP升高、不确定的echo - LAP以及AF,与正常echo - LAP相比,各自独立地与运动能力降低相关。这些发现表明,在HFpEF中无创性LAP评估对于调整减轻淤血的治疗可能具有潜在的实用性。
Early, non-invasive identification of heart failure with preserved ejection fraction (HFpEF) patients with congestion may allow for timely tailoring of decongestive therapies. The 2016 American Society of Echocardiography / European Association of Cardiovascular Imaging guidelines provide an algorithm to assess for elevated left atrial pressure (LAP); the associations of echocardiographic LAP (echo-LAP) with clinical status and disease progression in HFpEF are unclear. We categorized participants in the Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in HFpEF (RELAX) trial into 1 of 4 pre-specified guideline-based echo-LAP categories: 1) normal, 2) elevated, 3) atrial fibrillation (AF) at the time of echocardiography, or 4) indeterminate. We evaluated the associations of echo-LAP categories with baseline exercise capacity, change in exercise capacity, and change in NT-proBNP over 24 weeks. Of 216 participants, 199 had mitral inflow Doppler echocardiography for LAP categorization. Participants with elevated echo-LAP (n=81) or AF (n=57) were older and had higher prevalence of kidney dysfunction. Compared with the normal echo-LAP group (n=28), elevated echo-LAP and AF were each independently associated with a greater reduction in peak oxygen consumption over 24 weeks after adjusting for baseline values and clinical covariates (β-coefficient for elevated echo-LAP: −1.55 [95% CI: −2.59, −0.51], p=0.004; β-coefficient for AF: −1.33 [95% CI: −2.49, −0.17], p=0.03). Indeterminate echo-LAP (n=33) was also independently associated with a reduction in exercise capacity at 24 weeks compared with normal echo-LAP (β-coefficient: −1.35 [95% CI: −2.51, −0.19], p=0.02). Finally, elevated echo-LAP and AF were significantly associated with increases in NT-proBNP over 24 weeks compared with normal echo-LAP. In chronic HFpEF, elevated echo-LAP and indeterminate echo-LAP, as defined by contemporary guidelines, and AF were each independently associated with a reduction in exercise capacity compared with normal echo-LAP. These findings suggest potential utility of non-invasive LAP assessment in HFpEF for tailoring treatments that decrease congestion.
慢性(MAGGIC)心力衰竭风险评分的荟萃分析全球组:验证一种简单的工具,用于预测心力衰竭的发病率和死亡率,并保留了射血分数。
DOI: 10.1161/jaha.118.009594
发表时间: 2018-10-16
影响因子: 5.4
作者:
Rich JD;Burns J;Freed BH;Maurer MS;Burkhoff D;Shah SJ
通讯作者: Shah SJ
DOI: 10.1161/circheartfailure.112.969071
发表时间: 2012-09-01
影响因子: 9.7
作者:
Redfield, Margaret M.;Borlaug, Barry A.;Braunwald, Eugene
通讯作者: Braunwald, Eugene
DOI: 10.1161/circheartfailure.114.001192
发表时间: 2014-07
期刊: Circulation. Heart failure
影响因子: --
作者:
Mohammed SF;Borlaug BA;McNulty S;Lewis GD;Lin G;Zakeri R;Semigran MJ;LeWinter M;Hernandez AF;Braunwald E;Redfield MM
通讯作者: Redfield MM
DOI: 10.1093/ehjci/jex067
发表时间: 2017-09-01
影响因子: 6.2
作者:
Lancellotti, Patrizio;Galderisi, Maurizio;Popescu, Bogdan A.
通讯作者: Popescu, Bogdan A.
DOI: 10.1093/ehjci/jev014
发表时间: 2015-03-01
影响因子: 6.2
作者:
Lang, Roberto M.;Badano, Luigi P.;Voigt, Jens-Uwe
通讯作者: Voigt, Jens-Uwe